FDA approves Novocure’s new flexible HFE arrays for glioblastoma treatment

Novocure has received FDA approval for its innovative Head Flexible Electrode (HFE) transducer arrays, designed to enhance the comfort of glioblastoma multiforme (GBM) patients using ... Read More